Answer
Mirikizumab’s geometric mean half-life is approximately 9.3 days in patients with either ulcerative colitis or Crohn’s disease, with coefficients of variation of 40% and 26%, respectively.
Sources for this answer
- Omvoh 100 mg solution for injection in pre-filled penEli Lilly and Company Limited · emc · SmPC §5.2 Pharmacokinetic properties · Version 4Document updated
Sources checked